|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Trimetazidine,a metabolic modulator,has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy显示文摘 | Tuunaen H Engblom E Naum A | 2008 | Circulation2008，118，： | 1 |
| 2 | Trimetazidine, a metabolic modulator, has cardiac and extracardiae benefits in idiopathic dilated eardiomyopathy 显示文摘 | Tuunanen H Engblom E Naum A | 2008 | Circulation2008，118，12： | 1 |
| 3 | Factors affecting length of productive life in Swedish commercial sows显示文摘 | ENGBLOM L LUNDEHEIM N STRANDBERG E | 2008 | J Anim Sci2008，10，12： | 1 |
| 4 | Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy显示文摘 | Tuunanen H Engblom E Nauru A | 2008 | Circulation2008，118，12： | 1 |
| 5 | Trimetazidine di- hydrochloride dibydrochloride, ametabolic modular or, has cardiac and ext- racardiae benefits in idiopathic dilated cardiomyopathy 显示文摘 | TuunanenH Engblom E Naxim A | 2008 | Circulation2008，118，12： | 1 |
| 6 | The endocardial extent of reperfused first - time myocardial infarction is more predictive of pathologic Q waves than is infarct transmurality: a magnetic resonance imaging study 显示文摘 | Engblom H Carlsson MB Hedstrom E | 2007 | Clin Physiol Funct Imaging2007，27，2： | 1 |
| 7 | Neurologic mani- festations of infective endocarditis: a 17-year experience in a teaching hospital in Finland 显示文摘 | Heiro M Nikoskelainen J Engblom E | 2000 | Arch Intern Med2000，160，18： | 1 |
| 8 | Size and transmural extent of firsttime reperfused myocardial infarction assessed by cardiac magnetic resonance can be estimated by 12 -lead electrocardiogram 显示文摘 | Engblom H Hedstrom E Heiberg E | 2005 | Am Heart J2005，150，： | 1 |
| 9 | Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy 显示文摘 | Tuunanen H Engblom E Naum A | 2008 | Circulation2008，118，12： | 1 |
| 10 | Trimetazidine, a metabolic mod- ulator,has cardiac and extracardiac benefits in idiopathic dilated cardio- myopathy显示文摘 | Tuunanen H Engblom E Nauru A | 2008 | Circulation2008，118，12： | 1 |
| 11 | Inflammatory response : pathway across he blood brain barrier显示文摘 | MONICA E K ENGBLOM D SAHA S | 2001 | Nature2001，410，6827： | 1 |
| 12 | Troponin-specific an- toantibody interference in different cardiac troponin I assay configura- tions显示文摘 | Savukoski T Engstrom E Engblom J | 2012 | Clin Chem2012，58，6： | 1 |
| 13 | Trimetazidine,a metabolic modulator,has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy显示文摘 | Tuunanen H Engblom E Naum A | 2008 | Circulation2008，118，12： | 1 |
| 14 | Trimetazi- dine, a metabolic modulator, has cardiac and extracardi- ac benefits in idiopathic dilated cardiomyopathy 显示文摘 | Tuunanen H Engblom E Naum A | 2008 | Cir- culation2008，118，12： | 1 |
| 15 | Troponin-specific au- toantibody interference in diffent cardiac troponin I assay config- urations显示文摘 | Savukoski T Engstrfim E Engblom J | 2012 | Clin Chem2012，58，6： | 1 |
| 16 | Decreased myocardial free acid up take in patients with idiopathic dilated cardiomyopathy:evidence of relationship with insulin resistance and left ventricular dysfunction显示文摘 | Tuunanen H Engblom E Naum A | 2006 | J Card Fail2006，12，8： | 1 |
| 17 | Echncaiography in Fabry dis- ease : diagnostic value of emlocardial lxmter binary appearance显示文摘 | Koskenvuo JW Engblom E Kantnla IM | 2008 | Clin Physiol Funct Imaging2008，29，3： | 1 |
| 18 | Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy显示文摘 | TUUNANEN H ENGBLOM E NAUM A | 2008 | Circulation2008，118，12： | 1 |
| 19 | Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy显示文摘 | Tuunanen H Engblom E Naum A | 2008 | Circulation2008，118，12： | 1 |
| 20 | Size and transmu- ral extent of first-time reperfused myocardial infarction assessed by cardiac magnetic resonance can be estimated by 12-lead elect rocardiogram 显示文摘 | Engblom H Hedstrtim E Heiberg E | 2005 | Am Heart J2005，150，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员